Detalhe da pesquisa
1.
Identification of the Human Skeletal Stem Cell.
Cell
; 175(1): 43-56.e21, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30241615
2.
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 24(4): 392-402, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878237
3.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
Lancet
; 399(10328): 909-923, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248186
4.
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Ann Allergy Asthma Immunol
; 130(1): 60-66, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569802
5.
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough.
Lung
; 201(2): 111-118, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879087
6.
Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough.
Lung
; 200(6): 717-724, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348054
7.
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.
Lung
; 200(4): 423-429, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895098
8.
Considerations for Social Needs Screening in a Local Public Health Agency.
J Public Health Manag Pract
; 28(2): E441-E445, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475367
9.
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
Lung
; 199(2): 121-129, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825965
10.
Neuronal delivery of Hedgehog directs spatial patterning of taste organ regeneration.
Proc Natl Acad Sci U S A
; 115(2): E200-E209, 2018 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29279401
11.
Does recall period matter? Comparing PROMIS® physical function with no recall, 24-hr recall, and 7-day recall.
Qual Life Res
; 29(3): 745-753, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31701432
12.
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.
Am J Respir Crit Care Med
; 207(11): 1539-1542, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996347
13.
Identification and characterization of an injury-induced skeletal progenitor.
Proc Natl Acad Sci U S A
; 112(32): 9920-5, 2015 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216955
14.
Psychometric validation of the dysmenorrhea daily diary (DysDD): a patient-reported outcome for dysmenorrhea.
Qual Life Res
; 26(8): 2041-2055, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405780
15.
Understanding Programming of Fungal Iterative Polyketide Synthases: The Biochemical Basis for Regioselectivity by the Methyltransferase Domain in the Lovastatin Megasynthase.
J Am Chem Soc
; 137(50): 15688-91, 2015 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26630357
16.
Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.
Clin Exp Rheumatol
; 33(4): 537-44, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26146786
17.
A qualitative study to develop a patient-reported outcome for dysmenorrhea.
Qual Life Res
; 24(1): 181-91, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048731
18.
Comparative analysis of the effects of nomegestrol acetate/17 ß-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea.
Eur J Contracept Reprod Health Care
; 20(4): 296-307, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712537
19.
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
Cell Metab
; 7(1): 68-78, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18177726
20.
Analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting with moderately and highly emetogenic chemotherapy.
Future Oncol
; 9(10): 1443-50, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23987791